XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.4
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Income Statement [Abstract]    
Sales $ 33,901 $ 31,438
Cost of sales 26,326 24,808
Gross profit 7,574 6,630
Selling, general and administrative expenses 6,391 5,792
Equity earnings (loss) in AmerisourceBergen 100 (1,373)
Operating income (loss) 1,283 (535)
Other income 2,617 63
Earnings (loss) before interest and tax 3,900 (472)
Interest expense, net 86 136
Earnings (loss) before tax 3,814 (607)
Income tax provision (benefit) 275 (207)
Post tax (loss) earnings from other equity method investments (7) 15
Net earnings (loss) from continuing operations 3,531 (385)
Net earnings from discontinued operations 0 87
Net earnings (loss) 3,531 (299)
Net (loss) earnings attributable to noncontrolling interests - continuing operations (48) 5
Net earnings attributable to noncontrolling interests - discontinued operations 0 4
Net earnings (loss) attributable to Walgreens Boots Alliance, Inc. 3,580 (308)
Net earnings (loss) attributable to Walgreens Boots Alliance, Inc.:    
Continuing operations 3,580 (391)
Discontinued operations 0 83
Total $ 3,580 $ (308)
Basic net earnings (loss) per common share:    
Continuing operations (in dollars per share) $ 4.13 $ (0.45)
Discontinued operations (in dollars per share) 0 0.10
Total (in dollars per share) 4.13 (0.36)
Diluted net earnings (loss) per common share:    
Continuing operations (in dollars per share) 4.13 (0.45)
Discontinued operations (in dollars per share) 0 0.10
Total (in dollars per share) $ 4.13 $ (0.36)
Weighted average common shares outstanding:    
Basic (in shares) 865.8 865.3
Diluted (in shares) 867.6 865.3